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Abstract
Background The lelation between a family history of heart attack and the occurrence of early myocardial infarction (MI) has
not been studied extensively m women In addition, whether recogmzed and newly-identified coronary heart disease (CHD) nsk
factors account for the familial aggregation of these events remams unknown We theiefore exammed these questions in a
population-based case-control study among female 18- to 44-year-old residents of western Washington State Methods and
results The patients consisted of 107 women with first acute MI, and the control subjects compnsed 526 women similar m age
identified from the Community and without a history of recogmzed chnical coronary heart disease or stroke Tramed Interviewers
used a structured questionnaire to ehcit a detailed history of heart attack m first-degree relatives Information about other known
MI risk factors was collected and biochemical measurements performed, and common polymorphisms in vanous candidate genes
were determmed The rate of MI among first-degree relatives of MI cases was twice äs high äs among first-degree relatives of
controls (relative risk, l 96, 95% confidence interval (CI), l 46-2 48), this association was present for each familial relationship
Siblmg history of MI but not parental history was associated with MI, after controllmg for estabhshed CHD nsk factors In a
subsample of subjects with blood measurements, further adjustment for lipids, lipoprotems and specific genetic nsk factors slightly
reduced the association with siblmg MI history (from odds ratio (OR), 517, 95% CI, 193-1385 to OR, 397, 95% CI,
0 92-17 17) Concluswn Family history of MI is positively associated with the risk of early MI m women While the association
with parental history of MI is mediated through the clustermg of other common risk factors, the association of siblmg history of
MI with early-onset MI in young women is only partially explamed by the clustermg of estabhshed and newly-identified nsk
factors © 2001 Eisevier Science Ireland Ltd All rights leserved
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1. Introduction
There is ample evidence that myocardial infarction
(MI) tends to cluster m famihes [1,2] Since the major
documented nsk factors for the development of coro-
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nary heart disease (CHD) have important genetic deter-
minants, the question anses whether aggregation of MI
is due to the familial aggregation of these known risk
factors or to genetic and/or environmental determi-
nants that family members share, which exert their
effects through äs yet unknown mechamsms In several
studies, a family history of MI or CHD was shown to
be a strong predictor of CHD, even after adjustment
for other risk factors [1-3], yet, this issue has remamed
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controversial [4]. Extensive evidence suggests that
hereditary determination may be particularly important
in patients with early onset disease and in affected
females [1,2,5]. Women and young men are intrinsically
less susceptible and therefore must carry a heavier
bürden of predisposing genes to manifest early-onset
MI and thereafter transmit a heavier 'genetic predispo-
sition' to offspring. However, this possibility does not
preclude alternative explanations for these age and
maternal effects, such äs shared lifestyle risk factors.
We examined evidence for familial aggregation of MI
risk associated with family history of heart attack
within a case-control study of women with early-onset
MI, and tested the hypothesis that this association is
independent, at least in part, of other established and
newly-identified CHD risk factors.
2. Methods
The basic design of the case-control study has been
described in detail [6]. Briefly, the subjects were drawn
from a study of incident cardiovascular disease among
women 18-44 years of age residing in three contiguous
counties of western Washington State. Eligible case
patients were women diagnosed with a first fatal or
nonfatal MI between l July 1991 and 28 February
1995. Cases were identified through the review of hospi-
tal discharge diagnoses provided by all hospitals within
the study region, incident reports from emergency med-
ical service Systems and death certificates listing out-of-
hospital deaths from cardiovascular disease and related
conditions. Criteria for MI were adapted from the
Cardiovascular Health Study [7], and were defined by
evidence of Symptoms, elevated enzymes, and electro-
cardiographic changes. Using these criteria, we iden-
tified 208 eligible MI patients, of whom 161 were living
at the time that we initiated recruitment. One hundred
and seven women were willing to participate in an
in-person interview, a response rate of 66.5%.
We used random-digit telephone dialing to identify a
control group of women 18-44 years old living in the
same area during the time period of the study [8]. We
recruited 526 such women, frequency matched on age.
The estimated response rate, incorporating both the
household screening and interview participation rates,
was 72.8%.
Data on each woman's family health history were
collected from both case patients and controls by
trained Interviewers using a structured questionnaire.
Information about first-degree relatives (each biological
parent, brother or sister) was obtained, including: age
at the time of interview or age at death, occurrence of
MI, and age of occurrence. In addition, participants
were asked to describe the cause of death of their
deceased relatives, particularly with regard to heart
attack. In a small-scale validation study of family his-
tory, the interview data of 59 cases and 288 controls
were compared with family history data ascertained
through the ambulatory care medical records. This
study detected a relatively strong concordance between
reported family history and medical record evidence for
both cases and controls (sensitivity, 0.69-0.70%; spe-
cificity, 0.74-0.82%).
The interview also covered other known or suspected
cardiovascular risk factors such äs: age, race, education,
weight and height, physician-diagnosed diabetes, hyper-
tension, or hypercholesterolemia, cigarette smoking,
physical activity, coffee consumption and dietary fat
intake. The structured interview elicited Information for
the time period preceding the MI or an equivalent date
for controls. In addition to the in-person interview, we
also collected nonfasting venous blood specimens from
79 MI case patients and 391 control subjects. Case
blood samples were obtained at least 3 months after the
event (mean, 8 months; median, 6.6 months). Plasma
total cholesterol, triglyceride and high-density lipo-
protein-cholesterol (HDL-C) were measured by enzy-
matic procedures on the Abbott Spectrum. HDL-C was
measured directly from the plasma after precipitation of
apoprotein B-containing lipoproteins. Plasma lipo-
protein (a) (Lp(a)) was measured using an enzyme-
linked immunosorbent assay technique that accounts
for the potential influence of apolipoprotein (a) size on
the accuracy of immunohistochemical detection [9].
These analyses were performed on a subset of case
patients (69 cases with all lipid measurements) and
controls subjects (220 subjects with all lipid measure-
ments) selected at random. Since the plasma lipid mea-
sures we made were based on blood specimens obtained
post-event for the cases, we were concerned that these
levels might have changed after the acute coronary
event and differ from those measured on these women
earlier in life. We therefore compared the post-event
plasma lipid concentrations to lipid level data ab-
stracted from medical records completed prior to the
reference dates of a subset of cases (n = 48) and con-
trols (n = 203). We found moderate-to-strong, statisti-
cally significant correlations between plasma lipid levels
and lipid levels from medical records. For total choles-
terol, plasma measures were less strongly correlated
with medical record levels among cases (R = 0.41, P <
0.004) than among controls (# = 0.66, P < 0.0001);
whereas for HDL-C, the correlations were similar
(cases, Ä = 0.78, P < 0.0001; controls, .R = 0.64, P<
0.0001). For triglycerides, the correlations were some-
what stronger among cases (R = 0.67, P < 0.0001) than
among controls (R = 0.50, P < 0.0001). These compari-
sons suggest that our data on post-event lipid levels are
likely to capture the most important Information re-
garding women's earlier (pre-event) lipid levels, and
that the data are not systematically different among
cases äs compared with controls.
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Polymorphisms in the genes for factor V (R506Q),
prothrombin (G20210A), MTHFR (C677T) and
platelet glycoprotein Ilb (Ile843Ser) were determined äs
previously described [10-13]. Small, dense low-density
lipoprotein (LDL) phenotype (A-predominance of
large, buoyant LDL particles, or B-predominance of
small, dense LDL particles) was determined by dena-
turing gradient gel electrophoresis [14]. All laboratory
personnel were blinded to the case or control status of
the samples.
For each participant, person-years accumulated by
family members and the number of MI events within
the family were counted. Person-years of relatives at
risk were accumulated from birth until age at interview
or age at death, or until age at event for relatives who
experienced a MI. For each first-degree relative (par-
ents and siblings), specific incidence rates were calcu-
lated and the relative risks were estimated by dividing
the rate (history of MI among a relative per 1000
person-years) among the MI cases by the rate among
the controls; confidence limits for these ratios were also
calculated [15]. We then used unconditional logistic
regression analysis to assess the relationship of family
history with the risk of MI, while adjusting for differ-
ences in familial person-years and for potential con-
founding and mediating factors. Four sets of logistic
regression models were fit with familial history of MI in
first-degree relatives (number of events and familial
person-years) äs main predictors: (1) an unadjusted
model; (2) a model that included äs covariates the age
of case and control subjects; (3) a model with addi-
tional adjustments for common CHD risk factors; and
(4) a model similar to (3) with additional adjustments
for lipids, lipoproteins and genotypic data variables
which were examined on a subsample of 69 cases and
220 controls. Except for age, terms for other covariates
were retained in the model if they were significant at the
0.1 level.
3. Results
The study subjects were predominantly white and
cases were, on average, 1.8 years older than the sample
of controls (Table 1). Cases exhibited a higher preva-
lence of diabetes, hypertension, hypercholesterolemia
and current smoking. Case patients were less educated,
weighed more given their height, had higher mean
coffee intake and consumed more fat in their diet, and
were less likely to participate in regulär leisure-time
vigorous physical activity than control subjects.
In the subsample of participants with blood measure-
ments, case patients had higher mean total cholesterol,
triglycerides and Lp(a) concentrations and lower mean
levels of HDL-C than controls. The LDL subclass
pattern B was more prevalent in MI patients (20.6%)
than in controls (5.0%). The frequency of the factor V
R506Q mutation, the prothrombin G20210A variant
and the platelet glycoprotein Ilb Ser843 variant were
also higher in MI cases than in controls. No difference
in the MTHFR C677T mutation was observed between
MI cases and controls.
For each familial relationship, the rate of MI in
family members among cases exceeded the correspond-
ing rate among family members of controls (Table 2).
The rate ratio was 1.68 (95% confidence interval (CI),
1.11-12.48) in fathers, 2.16 (95% CI, 1.07-4.12) in
mothers and 1.73 (95% CI, 1.22-2.40) for MI in either
mothers or fathers. The rate of MI among siblings of
cases was 28.5 per 10000 person-years, compared with
a rate of 4.1 per 10000 person-years in siblings of
controls, resulting in a relative risk (RR) of 6.95 (95%
CI, 3.29-15.37). Overall, the rate of MI among first-de-
gree relatives of MI cases was almost 100% higher than
the rate in first-degree relatives of controls (RR, 1.96;
95% CI, 1.46-2.84).
We assessed the relative odds of MI associated with
a positive family history of MI in various family mem-
Table l
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a Plus-minus values are means + S.D. Lipids, lipoproteins and
genotypic values derived from subsamples of cases and controls with
blood samples.
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Table 2
Famihal person-years at nsk, number of MI events and rates of events from MI in first-degree relatives
Relative Case patients Control subjects Rate ratio 95% CI




































































a Years were accumulated from birth until age at interview or age at death, or until age at event for those who survived their first MI
bPer 10000 years
bers and examined the role of conventional risk factors
on the familial aggregation of MI (Table 3). In the
unadjusted model, the strength of the associations were
in the Order of sisters' history, brothers' history, moth-
ers' history and fathers' history with odds ratlos (ORs)
(95% CI) of 8.78 (2.17-35.43), 4.84 (1.92-12.21), 2.21
(1.12-4.35), and 149 (0.88-2.53), respectively. While
the associations with sibling history and any familial
history were not altered upon the adjustment for age,
parental history of MI was only marginally associated
with subject's risk of MI following age adjustment.
Inclusion of conventional risk factors äs covariates in
the multivariate adjusted model (Table 3, model B)
appreciably altered the associations with any parental
history and any first-degree family history. Based on
this sample, the estimated odds of MI occurnng in a
subject increased by 1.52 times with each additional
MI-affected first-degree relative (95%CI, 1.00-2.32),
after adjustment for other risk factors and person-years
at risk among first-degree relatives. This association is
considerably lower than that obtained from the unad-
justed (OR, 2.15) and the age-adjusted (OR, 2.12)
logistic models. The introduction of the family history
variables into the logistic model did not change consid-
erably the coefficients for hypercholesterolemia,
cigarette smoking and fat consumption, while a modest
change was observed in the coefficients for low educa-
tion, diabetes, physical activity, coffee consumption and
body mass index (BMI) (data not shown).
Separately for cases and controls, we compared the
risk factors between subjects with blood measurements
and subjects without. For cases, only BMI slightly
differed between those with blood measures and with-
out (P = 0.08). Controls with blood measures were
slightly older and were more likely to be diagnosed with
high cholesterol. In addition, the significant positive
association between age-adjusted family history and MI
risk in the subgroup of cases and controls for whom
blood measurements were available was similar to that
observed in the total sample (i.e. the ORs associated
with family history in first-degree relatives were 2.08
(95% CI, 1.37-3.16) and 2.12 (95% CI, 1.54-2.91),
respectively). We therefore investigated the possible as-
sociation of family history with myocardial infarction
after additional adjustment for plasma lipids, lipo-
proteins and genotypes data. This further adjustment
tended to reduce the strength and statistical significance
of the point estimates for family history (e.g. the OR
associated with risk of MI and parental history of MI
decreased from 1.12 (Table 3, model B, observed in the
total sample) and 1.28 (95% CI, 0.60-2.73; model B,
observed in the subsample with blood measurements) to
0.89 (95% CI, 0.4-2.2)(Table 3, model C); and the OR
associated with siblings history of MI decreased from
5.17 (Table 3 model B, observed in the total sample)
and 4.58 (95% CI, 1.2-17.2; model B, observed in the
subsample with blood measurements) to 3.97 (95% CI,
0.9-17.2) (Table 3, model C).
We also determmed whether there was a differential
pattern of familial clustering of MI risk according to
the presence or absence of traditional risk factors. The
combination of family history and hypertension re-
sulted in a 2.9-fold increased risk compared with those
without family history and hypertension, exceeding the
separate effects of these two risk factors (OR, 1.14 and
0.67 for normotensive subjects with family history and
hypertensive subjects without family history, respec-
tively). Other interactions examined (e.g. family history
with age, education, diabetes, hypercholesterolemia,
smoking, physical activity, coffee, fat intake and BMI)
did not show any such effect modification. In addition,
we examined whether family history of early MI was
more strongly related to the early onset of MI in
women. Since most events occurring among siblings are
early-onset events, we conducted this analysis among
parents only. The odds ratios for early parental MI
(fathers before age 60 years; mothers before age 65
years) were similar to those presented for the total
group (Table 3).
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4. Discussion
We found that a family history of MI, particularly
sibling history of MI, is associated with an increased
risk of early onset of MI in women. Our data also
provide evidence that parental history of MI but not
sibling history of MI may be primarily mediated by
familial aggregation of common CHD risk factors.
Although familial aggregation of CHD has been
demonstrated m several retrospective [3] äs well äs
prospective [1,2,5] studies, few have exammed the role
of parental and sibling history of CHD in young
women [1,2,5,16,17]. The higher odds associated with
sibling history than parental history also may indicate
an increased risk associated with a family history of
heart attack when the condition occurs early in life or
when both genes and environmental/behavioral factors
are shared.
Our results are consistent with other studies. In one
study based on men and women, family history at
young age was significantly associated with early onset
of coronary artery disease äs determined by arteriogra-
phy [18]. In 520 female heart patients, the extent of
coronary occlusive disease was also found to be corre-
lated with parental history of MI [19]. Another study
demonstrated that the risk of early-onset CHD was
increased 2.7-fold for female and 1.6-fold for male
first-degree relatives of women with connrmed coronary
death before age 55, äs compared with the risks of
relatives of the controls [20]. This pattern of clustering
of MI risk with respect to the gender of the family
relatives is also supported by our study. In a 9-year
follow-up of over 4000 men and women aged 40-79
years, positive family history in men, but not in women,
was significantly associated with an excess risk of car-
diovascular and CHD death [1]. Yet, m a large cohort
of young women, parental history of early onset of MI,
was a significant predictor of nonfatal and fatal MI [2].
A recent study reported a relative hazard of coronary
death of 15.0 for female monozygotic twins and 2.6 for
female dizygotic twins if their co-twins had died of
CHD before the age of 65 [21]. However, this difference
was not statistically significant if the co-twin died of
CHD after the age of 75.
Although familial aggregation of CHD has been
clearly demonstrated in women, the mechanisms under-
lying this aggregation are uncertain. In multivariate
analysis, parental history appeared to be mediated by
familial aggregation of other common risk factors.
Such a finding suggests that, äs the methodology of
family history studies improves and more newly-iden-
tified risk factors are added to predictive models, the
resulting independent effect of family history become
much weaker and, even, nonsignificant. However, the
introduction of sibling family history of MI äs the last
term in the stepwise logistic regression model did not
alter considerably the coefficients for the risk factors in
the antecedent model. While this suggests that the MI
risk associated with sibling history was independent of
other risk factors, it does not imply lack of a familial
influence on diabetes, hypercholesterolemia, BMI,
smoking or physical activity in our data. Rather, it
suggests that familial aggregation of these risk factors
accounts for, at most, only a small part of the cluster-
ing of MI in young family members (i.e. siblmgs). The
clustering of early onset MI among siblings, therefore,
appears to reflect characteristics other than the factors
that were measured in our study. Yet, in the present
study, the sample size provides a less stable estimate of
the risk associated with sibling history of MI than the
risk associated with parental history of MI.
Table 3













































































d Adjusted for age of case patients and control subjects
b Adjusted for age, education, diabetes, hypertension, hypercholesterolemia, smoking, physical activity, coffee and fat consumption, and body
mass mdex
c Estimates (denved from a subsample of 69 cases and 220 contiols) were adjusted for total cholesterol, tnglycende, HDL-C, Lp(a), LDL
subclass, and polymorphisms m the genes for factor V, piothrombin, MTHFR and platelet glycoprotem Ilb in addition to other covanables hsted
in footnote b
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That aggregation of MI among siblings is largely
unexplained by familial patterns in these risk factors is
consistent with other retrospective [3,22], and prospec-
tive [2,16,23] studies. Yet, at least in some retrospective
studies, the authors have concluded that the risk of
CHD associated with a positive family history appears
to be fully mediated by familial aggregation of common
risk factors [4]. Methodological difficulties, related to
identification of positive versus negative family history,
complete assessment of known risk factors, and control
for the covariation of elevated risk factor profiles and
positive family history may account for much of the
differences between studies regarding the MI risk at-
tributed solely to family history.
Several alternative interpretations of the independent
effect of a positive sibling history of myocardial infarc-
tion in the prediction of MI risk may be considered.
First, the association may be operating via unobserved
risk factors. We were able to determine total plasma
cholesterol, triglyceride, HDL-C and Lp(a) on nonfast-
ing specimens obtained from a subsample of cases and
controls. The adjustment for these lipid variables and
for allelic Variation in various candidate genes had a
small effect on the strength of the association between
sibling history and the risk of MI. Nevertheless, resid-
ual confounding may account for some of our findings.
Alternatively, this association may be due to genetic
and/or environmental determinants that siblings share
that exert their effects through yet unknown risk
factors.
Positive family history also may be a marker for
increased susceptibility to the deleterious effects of the
traditional risk factors. For example, our results sug-
gest that individuals from a family prone to MI may
experience a greater risk of MI if they are hypertensive
than someone with hypertension but without such fam-
ily history. No evidence for other first-order interac-
tions between family history and genotypic information
and with other CHD risk factors was indicated.
In contrast, some studies have reported that family
history may be most important in individuals who are
otherwise at low risk for CHD [5,19,24]. Yet, in our
study, no significant differences in odds ratios have
been shown upon stratifying the study participants
according to a composite risk score based on diabetes,
hypertension, hypercholesterolemia, low education,
smoking, physical activity, coffee drinking and fat con-
sumption (probability value from the multivariate logis-
tic regression model was 0.64 for family history χ risk
score interaction). Nonetheless, family history of MI
could modify the risk associated with other risk factors
not measured in the present study.
A number of limitations are inherent in the present
study. A potential drawback of these data is the lack of
a füll validation of family history. In the Framingham
study, analysis of the accuracy of reported paternal
history of coronary artery disease death revealed that
only 17% of the reports were discordant; the sensitivity
was 0.59, and the specificity was high at 0.95 [5]. Other
investigators have detected a relatively strong concor-
dance between family history of MI/CHD ascertained
by self-report and through medical records (a sensitivity
of 67-85% and a specificity of 95-97%) [25-31].
We included only MI survivors, and therefore we
cannot exclude the possibility that associations seen in
our study are due in part to early case fatality among
the MI patients without family history. Such a bias
potentially could occur if MI patients without a family
history tended to delay seeking medical care after the
appearance of Symptoms. We have, however, no data
on this issue and no reason to assume this supposition
to be true.
In retrospective studies, selection and recall biases are
potential problems. Unfortunately, we did not collect
data on family history from nonrespondents. However,
we performed some analyses on variables for which we
did collect data from nonrespondents and none of the
differences was significant or overwhelmingly strong,
and adjustment for nonresponse when estimating asso-
ciations made little difference in the associations [32]. In
addition, our comparison of self-report with medical
records has shown that study participants provided an
accurate information about family history variables
that was essentially the same for cases and controls.
Based on this comparison between respondents and
nonrespondents, the small validity study, and the fact
that similar associations between family history and
CHD have been seen in case-control studies and
prospective studies that are less susceptible to selection
and recall biases, we feel that these biases are not
remarkable in the present study.
Our data indicate an overall positive association of
family history of MI with the risk for MI in young
women. While, the association with parental history is
mediated through the clustering of other risk factors,
the association of sibling history of MI is only partially
explained by the clustering of established and newly-
identified risk factors. Further identification of the ge-
netic and/or environmental factors will provide a major
tool for the understanding and prevention of the MI,
especially among susceptible women with a positive
family history of the disease.
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